A study of diabetes mellitus within a large sample of Australian twins. by Condon, Julianne et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A study of diabetes mellitus within a large sample of Australian
twins.
Citation for published version:
Condon, J, Shaw, JE, Luciano, M, Kyvik, KO, Martin, NG & Duffy, DL 2008, 'A study of diabetes mellitus
within a large sample of Australian twins.' Twin Research and Human Genetics, vol 11, no. 1, pp. 28-40.,
/10.1375/twin.11.1.28
Digital Object Identifier (DOI):
/10.1375/twin.11.1.28
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Twin Research and Human Genetics
Publisher Rights Statement:
© Condon, J., Shaw, J. E., Luciano, M., Kyvik, K. O., Martin, N. G., & Duffy, D. L. (2008). A study of diabetes
mellitus within a large sample of Australian twins.Twin Research and Human Genetics, 11(1), 28-40doi:
/10.1375/twin.11.1.28
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
28 Twin Research and Human Genetics Volume 11 Number 1  pp. 28–40
Twin studies of diabetes mellitus can help elucidate genetic and environmental factors in eti-
ology and can provide valuable biological samples for
testing functional hypotheses, for example using
expression and methylation studies of discordant
pairs. We searched the volunteer Australian Twin
Registry (19,387 pairs) for twins with diabetes using
disease checklists from nine different surveys
 conducted from 1980–2000. After follow-up question-
naires to the twins and their doctors to confirm
diagnoses, we eventually identified 46 pairs where
one or both had type 1 diabetes (T1D), 113 pairs with
type 2 diabetes (T2D), 41 female pairs with gesta-
tional diabetes (GD), 5 pairs with impaired glucose
tolerance (IGT) and one pair with MODY. Heritabilities
of T1D, T2D and GD were all high, but our samples
did not have the power to detect effects of shared
environment unless they were very large. Weight
differences between affected and unaffected co-
twins from monozygotic (MZ) discordant pairs were
large for T2D and GD, but much larger again for dis-
cordant dizygotic (DZ) pairs. The bivariate genetic
analysis (under the multifactorial threshold model)
estimated the genetic correlation between body
mass index (BMI) and T2D to be 0.46, and the envi-
ronmental correlation at only 0.06.
Diabetes mellitus is an etiologically and clinically het-
erogeneous group of metabolic diseases defined by
hyperglycemia that is caused by defects in insulin secre-
tion and/or insulin action. Depending on the underlying
pathogenetic mechanism, the clinical course of the dif-
ferent types varies from a severe, rapidly onset disease
with potentially high mortality to a slowly progressing
disease that may go unnoticed for many years even
while causing damage to target tissues. Diabetes mellitus
is associated with micro- and macrovascular complica-
tions including nephropathy, retinopathy, autonomic
and peripheral neuropathy and cardiovascular disease.
The classification of diabetes mellitus into the different
subtypes is based on pathogenesis and below follows a
description of some of these subtypes.
Type 1 diabetes (T1D) accounts for approximately
10% of all diabetes and consists of the rare variant,
idiopathic diabetes and the more common form,
autoimmune diabetes (T1aD), which is one of the most
common chronic diseases in children and adolescents
of European origin. It is characterized by an absolute
deficiency of insulin secretion, which results from a T-
cell mediated autoimmune destruction of the
pancreatic β cell. The patients are characterized by the
presence of autoantibodies to β-cell autoantigens and
have a lifelong requirement for exogenous insulin.
T1aD is a polygenic disorder resulting from a
complex interplay of genetic and environmental risk
factors. The dominant genetic susceptibility locus
(termed IDDM1) is the human leucocyte antigen
(HLA) region on chromosome 6, notably the Class II
immune response genes HLA DQ and DR.
Susceptibility alleles at the HLA locus (IDDM1) make
up approximately 45% of the genetic variance of
T1aD. Approximately 20 other loci, some of which
may have a modest influence on the development of
diabetes and others, which may prove to be false posi-
tives, have been reported and given IDDM
designation numbers. Associations with T1D risk
include the insulin gene-VNTR locus (IDDM2)
 chromosome 11p15 , CTLA4 (IDDM12) on chromo-
some 2q33 and PTPN22 on chromosome 1p13.
Environmental risk factors implicated in T1D include
viruses, dietary factors, nitrates and toxins. As these
risk factors for disease are common in the general
population, it is considered that known protective
alleles as well as low penetrance of susceptibility
genes may account for the low overall disease preva-
lence of 0.05 to 0.3%.
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Type 2 diabetes (T2D) is thought to account for
approximately 90% of all diabetes cases. T2D is also a
heterogeneous and multifactorial disease and is likely to
consist of a number of pathogenetic subgroups of cur-
rently unknown etiologies. T2D is typified by insulin
resistance (i.e., impaired insulin action), which is most
often accompanied by varying degrees of impaired
insulin secretion. Chronic hyperglycemia may cause
insulin resistance, termed ‘glucose toxicity’. Chronic
exposure to fatty acids, which in the short-term
increases insulin secretion mediated by GPR40, a β cell
fatty acid-activated receptor, promotes β cell death and
diabetes. T2D usually presents with obesity or a high
percentage of abdominal fat and is often coupled with
hypertension and/or dyslipidemia. In T2D, autoimmune
destruction of the β cell does not occur, but there is a
decrease in β cell mass thought to result from increased
β cell apoptosis.
A number of genes such CAPN10, encoding calpain
19, PPARG encoding peroxisome proliferator–activated
receptor gamma and KCNJ11 encoding the potassium
channel KIR 6.2. MODY1, MODY3 and the insulin
receptor genes, as well as the mitochondrial genome
have been implicated in elevated T2D risk (reviewed in
Barroso, 2005; O’Rahilly et al., 2005). Several recently
published genome-wide association scans have both
confirmed these associations, and described novel
strong associations to variants in noncoding regions
(Diabetes Genetics Initiative of Broad Institute, 2007;
Zeggini et al., 2007). Environmental risk factors
include the global shift toward more sedentary work
and lifestyle practises as well as dietary changes.
Gestational Diabetes (GD) is defined as any degree
of glucose intolerance that is initially observed during
pregnancy, irrespective of whether the diabetes onset
predates, or is maintained beyond, pregnancy. GD
results from pregnancy induced insulin resistance and
relative diminished insulin secretion. It is a major risk
factor for the development of T2D later in life as it as it
is believed to result from the same genetic and physio-
logical abnormalities that characterise T2D (Buchanan,
2005; Watanabe et al., 2007). GD patients diagnosed
early in pregnancy have a greater risk of developing
T2D postpartum than if diagnosed late in pregnancy.
The classical twin study is a powerful method used
to determine the relative significance of genetic and
environmental components in the etiology of a particu-
lar disease or trait. The primary aim of the classical
twin study is to compare the concordance rates (the
occurrence of the same disease/trait in both members of
a twin pair) of identical or monozygotic (MZ) twins,
who share a common set of genes, with those of non-
identical or dizygotic (DZ) twins, who, like siblings,
share on average 50% of their genes. If MZ concor-
dance rates are significantly higher than DZ rates, then
a substantial genetic contribution to the etiology of
disease can be inferred. The genetic sharing of MZ and
DZ twins, together with a unique degree of environ-
mental sharing beginning in utero, allows the
separation and quantification of the genetic, shared
environmental and unique environmental components
of the phenotypic variation of a disease/trait at the pop-
ulation level. Analysis of twins, therefore, allows the
estimation of disease heritability (h2) — the proportion
of variance in disease susceptibility due to genetic
factors. 
A number of studies of diabetes from the large pop-
ulation-based Scandinavian twin registries have been
published. These include both simple disease concor-
dance studies, and multivariate twin analyses of risk
factors such as birth weight or obesity. Hyttinen et al.
(2003) report data from 22,650 Finnish twin pairs born
since 1958. The risk to a MZ co-twin of a T1D patient
was 43%, but only 7.4% to a DZ co-twin, giving an
estimated heritability (h2) of 88% under the multifacto-
rial threshold model. These results are similar to those
obtained from 20,888 twin pairs from the Danish Twin
Registry (Kyvik et al., 1995), where the crude MZ
recurrence risk was 53% (DZ 13%, h2 = 72%), and in
smaller British and American clinic based MZ samples
(Redondo et al., 2001), at approximately 50% (after
allowing for censoring). In an earlier-born Finnish
cohort, the ‘Old Twin Cohort’ (Kaprio et al., 1992)
however, the MZ recurrence risk was significantly
lower at 23%, which was interpreted as reflecting
improvements in treatment since that era. A Finnish
study of 10,168 nontwin siblings of Type 1 diabetics
(Harjutsalo et al., 2005) obtained very similar esti-
mated recurrence risks (crude 6.4%) to those seen in
the DZ twins, suggesting that effects specific to a twin
pregnancy do not greatly influence recurrence risk. By
contrast, the Danish study (Kyvik et al., 1995) found
DZ twins to be more concordant than ordinary siblings
at 13% versus 7%.
With regard to Type 2 diabetes, there are fewer
good studies, probably due to the fact that there are so
many undiagnosed cases. The only population-based
study originates from an Old Finnish Cohort (Kaprio
et al., 1992), which gave a crude recurrence risk of
34% for MZ co-twins, and 16% for DZ co-twins. A
Danish study of a subsample of 303 twin pairs who
were all tested with an oral glucose tolerance test,
resulted in crude recurrence risks of 50% for MZ co-
twins and 37% for DZ co-twins, while the same risks
were 63% and 43% when cases with T2D and
impaired glucose tolerance were combined. The heri-
tability estimates were 0.26 for T2D and 0.61 for the
combined phenotype. A somewhat similar study was
conducted based on male twin pairs in the United
States (US), where it was found that 58% of the co-
twins of MZ twins with T2D had diabetes (Newman
et al., 1987; Poulsen et al., 1999).
Hitherto, there have not been any similar large pop-
ulation-based twin studies from other countries. In the
present article, we describe such a study of members of
the Australian National Health and Medical Research
Council Twin Registry.
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Methods
Subjects
The diabetes study participants were all active
members of the National Health and Medical
Research Council’s Australian Twin Registry (ATR),
which is a volunteer based twin registry comprising
approximately 25,000 twins at the time of ascertain-
ment for the study. The ATR, which was founded in
1978, comprises 10% to 20% of the estimated twin
population of Australia and has been shown through
extensive analyses to be representative of the
Australian population in regard to age, marital status,
education (Baker et al., 1996) and social attitudes.
The sampling frame for ascertaining diabetic twins
in the present study was derived from nine sources,
which span the history of the ATR. All had at least one
question relating to diabetes. Five were from studies
previously conducted at the Queensland Institute of
Medical Research (QIMR), including three mailed
Health and Lifestyle Questionnaires (HLQ), one tele-
phone interview and one venepuncture checklist. The
other four sources came directly from the ATR and
comprised two questionnaires and two recruitment
brochures. The sample collected from the QIMR
studies was based on individual information and
included data for age, sex and body mass index (BMI).
The ATR data were based on forms filled out by twin
pairs or their parents, so consequently it was not
known if both or just one of the twins had diabetes.
QIMR-Based Studies
1. Cohort 1. The first HLQ was posted during
1980–1982 to 5967 ATR twin pairs who were
born prior to 1965. As with all the HLQs, the
Cohort 1 questionnaire covered an extensive range
of health issues including questions related to
socio-demographic variables, personality measures,
health problems and risk factors for disease. Study
participants were asked the question: ‘Have you
any of the following conditions?’ Diabetes was
included in the list of 13 conditions and twins were
required to tick the appropriate box(es) if they or
their co-twin were affected. Questionnaires were
completed by 3807 twin pairs and 570 single
twins, giving a response rate of 69%. Of the 3807
pairs included in the diabetes sampling frame, 99
individuals ticked ‘yes’ for diabetes (see Table 1).
2. Aged Cohort. The HLQ was mailed out to 2281
twin pairs in three waves between November 1993
and July 1995. All twins were over 50 years of age
(mean age of respondents was 61.5 ± 8.7 years)
and 40% of them had previously participated in
the Cohort 1 HLQ. Completed questionnaires
were returned by 3116 individuals (1279 complete
pairs and 558 singletons). A two-page telephone
interview for nonresponders yielded a further 286
individual twins, providing an overall response
rate of 75%. For the questionnaire, participants
were asked the question: ‘Have you or your twin
ever had any of the following?’ Diabetes was listed
amongst 78 diseases and conditions. In the tele-
phone interview, diabetes was listed amongst nine
conditions and subjects were required to respond
‘yes’ or ‘no’ only for themselves. The Over 50s
HLQ yielded 194 individual twins who had self-
reported having diabetes.
3. Cohort 2. In 1990 a HLQ was mailed out to a
younger cohort (mean age 23.2 ± 2.2 years) com-
prising 4269 twin pairs born between 1964 and
1970. Completed questionnaires were returned by
5058 individuals, giving a response rate of 59%.
Participants were asked to respond ‘yes’ or ‘no’ to
the question: ‘Have you ever had any of the follow-
ing?’, which included diabetes amongst 17 diseases
and conditions. They were also asked to respond
‘yes’ or ‘no’ to the question for their co-twin, as well
as whether or not they or their co-twin had
acquired diabetes before age 14 or at age 14 or
older. Just 34 individuals from this younger cohort
responded positively to the questions.
4. SSAGA Blood. In 1992–1993 the 3807 twin pair
respondents from ‘Cohort 1’, as well as 64 pairs
who had participated in an alcohol challenge
study, were approached to undertake a psychiatric
telephone interview, which was a modified version
of the Semi-Structured Assessment for the Genetics
of Alcoholism (SSAGA). SSAGA was designed to
examine the psychological, physical and social
aspects of alcohol and other substance abuse as
well as other psychiatric disorders such as anxiety
and depression. Of the 6327 individuals who com-
pleted the interview, 3386 individuals (54%)
provided blood samples during 1993–1996. The
SSAGA blood checklist for venepuncture asked for
information relating to current medical problems,
including the question ‘Do you have diabetes?
yes/no’; 51 individuals responded ‘yes’ to diabetes.
5. Twin 89. In 1996–2000, a follow-up study to
‘Cohort 2’ was conducted in the form of a
SSAGA telephone interview, with over 6000
individuals interviewed at completion. At the
time of ascertainment for the diabetes study,
4824 individuals had been interviewed. Of these,
57 individuals had responded ‘yes’ to a question
asking if they had diabetes.
ATR-Based Studies
6. Senior Baseline questionnaire. Health question-
naires were mailed out to both adult and juvenile
twins during the period from 1985 to 1993.
Questions related to many aspects of health,
lifestyle and behavior. Diabetes was included
amongst a list of 19 medical conditions and twins
were requested to respond both for themselves and
their co-twin. For the ‘Senior’ questionnaire, 69
out of the 5605 twin pairs who responded,
reported that one or both twins had diabetes.
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7. Junior Baseline questionnaire. Six twin pairs
reported one or both twins having diabetes from a
total of 4943 twin pairs who responded to the
‘Junior’ questionnaire.
8. Registration form checklist. As part of a ‘general
medical history’ checklist, which was included in
an ATR registration brochure, twins were asked if
they or their co-twin had diabetes. The brochure,
which was used during 1991–1995, yielded 28
twin pairs where one or both had diabetes, out of
a total of 3228 responding twin pairs.
9. Newsletter disease checklist. This checklist was
sent out with the 1996 ATR newsletter and
included a registration form and a short family
health questionnaire. Individuals were asked if
they or their co-twin had a variety of diseases
including diabetes. One or both twins indicated
that they had diabetes in 143 out of the 5083 pairs
who completed the checklist.
As described, not all of the QIMR studies were inde-
pendent. Forty percent of the Aged Cohort participants
and nearly all of the SSAGA Blood participants were
derived from the 1980 Cohort 1 study. Cohort 2 and
Twin 89 had targeted the same younger cohort born
between 1964 and 1970. Therefore, there was consider-
able overlap between the studies in the participants
who had reported diabetes. Similarly, as all of the
QIMR twins were registered with the ATR, individuals
with diabetes were represented in both study groups.
The two ATR baseline questionnaires alone represented
80% of all twins registered with the ATR at the time of
the initiation of the diabetes study. On resolving the
considerable overlap of twins from all the various ques-
tionnaires, interviews and checklists, 384 twin pairs
had responded positively to diabetes, for one or both
twins, in at least one of the nine sources. After remov-
ing individuals who were deceased and those who had
asked not to be contacted for further studies (thus
removing 42 pairs), plus those lost to follow-up (37
pairs), 305 twin pairs from a total pool of 19,387 were
found to be eligible for the study.
Diabetes Questionnaires
The 305 twin pairs were initially sent an approach
letter asking if they would like to participate in a
study, which included taking part in a short telephone
interview, on diabetes.
Telephone interview. Interview questions included
those related to twin zygosity as well as current age,
height and weight. Individuals who identified them-
selves as having diabetes were questioned as to the
diabetes type as well as their age, height and weight at
the onset of the disease and treatment since that time,
including any hospitalisations and disease complica-
tions. All participants were questioned as to the health
status and/or cause of death for family members. The
diabetes telephone interview was completed by 506
individuals, giving a response rate of 83%. During the
interview 266 individuals reported having diabetes.
For those individuals who did not complete an inter-
view (n = 104), 44 refused to participate, 8 were
incapable of participating, 31 were unable to be con-
tacted and 21 had died. During the telephone
interview, participants who identified themselves as
having diabetes were also asked for permission to
Table 1
The Diabetes Mellitus Sampling Frame Showing the Number of Individuals/Pairs, Who Reported Diabetes, in Each of the Datasets
Sample Frame Data Sets Individuals Twin Pairs
Diabetes Total Prevalence Diabetes No Diabetes
(%) (One or both)
QIMR
Cohort 1 99 7614 1.3
Aged 194 3402 5.7
Cohort 2 34 5058 0.7
SSAGA 51 3386 1.5
Twin 89 57 4823 1.2
Total 375 16,065 2.3 265 8458
ATR
Senior 69 5605
Junior 6 4943
Registration 28 3228
Newsletter 143 5083
Total 217 15,353
Total unique pairs 384 19,387
Note: Raw data was available for individual twins and for twin pairs for the QIMR and the ATR samples respectively.
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contact their treating doctor to obtain any additional
medical information. They were also asked if they
would consent to providing a blood sample. Medical
release forms providing written consent for us to
contact treating doctor/s were sent out to the 257 indi-
viduals who had so agreed. Subjects were asked to
provide up to three names and addresses of doctors
who had diagnosed or treated their diabetes. On the
medical release forms subjects were also given the
option of providing any further relevant medical infor-
mation. The response rate for the return of medical
release forms was 97%.
Medical questionnaire. From the information pro-
vided, a total of 398 medical questionnaires were
posted to treating doctors on behalf of the 249 sub-
jects who had returned the medical release forms. The
overall response rate for the return of the medical
questionnaires was 87% (n = 347). Of the 249 sub-
jects, 148 had one medical questionnaire per person
returned, 86 individuals had two questionnaires
returned, 9 had three and 6 had no questionnaires
returned from their designated doctor.
Diagnosis Confirmation
For every individual with diabetes, the telephone inter-
view, medical release form and the medical
questionnaire/s were examined to verify diabetes diag-
nosis and type. Verification criteria included, but were
not confined to, treatment (at onset of disease as well as
current), BMI and age of onset. Approximately 30% of
the verified diagnoses were reviewed independently by
one of us, who is a diabetologist (J.E.S.). Following
this, 255 of the 267 diagnoses were classified as ‘defi-
nite’ and 12 (0.04%) were considered to be ‘highly
probable’. As such they were included in the analysis.
Zygosity
Opposite-sex pairs are automatically DZ. For same-sex
pairs, zygosity was established from standard interview
questions regarding twin similarity. The twins were
asked if their eye and hair color and their complexion
were the same as their co-twin’s and whether or not the
subjects considered themselves to be identical or non-
identical twins. The twins were also questioned as to
the ease with which parents/teachers/strangers could
distinguish them. Zygosity derived from questionnaire
information has been demonstrated to provide at least
95% agreement with zygosity based on extensive blood
typing (Martin & Martin, 1975) and genotyping (Ooki,
1990). For same-sex twin pairs who had participated in
parallel studies from which genotyping and blood
group information was available, these were used to
determine zygosity.
Analysis
Although disease status is a binary trait, for multifac-
torial disease a useful heuristic is to consider that there
is an underlying continuous distribution of liability, or
susceptibility to disease. An individual is affected for
disease when liability exceeds a threshold on the
underlying distribution, which is assumed to be nor-
mally distributed. This formulation is computationally
convenient but not as arbitrary as it first appears, in
that the model is equivalent to one positing risk to
continuously increase with liability score. For multi-
factorial diseases both genetic and environmental
factors contribute to liability and the proportion of
the total variation of liability resulting from genetic
factors gives a measure of ‘broad sense’ heritability at
the population level.
Probandwise concordance rates (2C/2C+D), where
C is the number of concordant twin pairs and D is the
number of discordant twin pairs, were estimated for
MZ and DZ twins for the three main types of dia-
betes, T1D, T2D and GD. For GD, as there were no
DZ concordant pairs, Haldane’s correction was
applied in order to estimate concordance.
Probandwise concordance rates, which do not vary
with ascertainment probability, estimate risk at the
individual as opposed to pair level and thus accurately
estimate the population casewise rate and may be
directly compared with other familial recurrence risk
rates. In twins with disease resulting from multifactor-
ial inheritance, probandwise concordance rates can be
used to estimate MZ and DZ co-twin correlations (rMZ
and rDZ), or correlations of liability. However, as con-
cordance rates are dependent on disease prevalence as
well as correlations of liability, if the correlation is
high but the disease has a low population prevalence
then the concordance will be reduced. A direct com-
parison of MZ and DZ population risk ratios (PPR,
which is the concordance divided by population
prevalence) may also be used to determine the under-
lying genetic structure of a disease; for example,
epistatic (hence polygenic) versus additive (either
monogenic or polygenic) genetic effects. Both these
approaches can be used as a basis for genetic hypothe-
sis testing in twin studies.
Structural equation modeling was used to elucidate
the variance components, that is genetic, shared environ-
mental and unique environmental components,
attributable to the familial correlations in liability esti-
mated from diabetes concordances. Multifactorial
threshold models that incorporate the effects of additive
genes (A), common environment (C), and unique envi-
ronment (E), were applied to the twin data for T1D,
T2D and GD using the Mx statistical modeling package.
The preferred model was determined from goodness-of-
fit statistics and Akaike’s information criteria (AIC),
which was calculated for each model and is given by
χ2–2df (where df is degrees of freedom). A small AIC
provides a measure of the best fitting and more parsimo-
nious model. Co-twin Pearson correlations used as
starting values for Mx were determined as:
Φ=ρRP=ad–bc/√((a+d)(c+d)(a+c)(b+d)) = √ χ2/N,
where χ2 is Pearson’s chi-square (Stuart & Ord, 1991).
To examine the genetic and environmental causes of
the relationship between BMI and diabetes, a bivariate
Cholesky decomposition was applied to the QIMR
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raw data for these two variables. Since ATR surveys
did not collect height and weight, they could not be
included in this analysis. Because diabetes status is a
binary variable, BMI was converted to an ordinal vari-
able with four categories to enable bivariate analysis
of these measures in Mx, and the model included an
adjustment to threshold values for the covariates of
age and sex for both variables. As the data were
obtained from five sources ranging over a period of 20
years, BMI for twins without disease was predicted at
the time of the diabetes interview using a flexible gen-
eralized additive regression model implemented in the
R statistical computing environment (R Core
Development Team, 2007). All other analyses were
conducted using R and SPSS. For GD, all analyses
were carried out for same-sex female twin pairs only.
Results
Diabetes Datasets
Of the 506 individuals (232 pairs and 42 singletons)
who completed the diabetes questionnaire, 342 were
female and 164 were male and 200 were MZ and 366
DZ. A total of 267 individuals were determined to have
some form of diabetes or impaired glucose tolerance
(IGT). Fifty-six individuals (46 twin pairs, either concor-
dant or discordant for disease, and 12 single twins) had
Type 1 diabetes, 152 (113 pairs and 17 single twins) had
Type 2 diabetes, 45 (41 pairs and 3 single twins) had
gestational diabetes. Thirty twin pairs did not have dia-
betes: 24 pairs self reported as nondiabetic during the
interview and a further 6 pairs were demonstrated not to
have diabetes from the medical questionnaires (Figure 1).
One MZ twin pair was  concordant for MODY and six
individuals,  consisting of one concordant and four dis-
cordant twin pairs, had IGT.
The individuals diagnosed as having T1D, T2D or
GD are described in Table 2. The mean BMI at onset
384 pairs
self report for
Diabetes Mellitus
79 pairs not
approached for
diabetes study
305 pairs
approached for
diabetes study
46 pairs
Type 1
Diabetes
104 individuals
were not
interviewed
506 individuals
completed
interview
113 pairs
Type 2
Diabetes
1 pair
MODY
5 pairs IGTF
30 pairs
no
Diabetes
41 pairs
Gestational
Diabetes
Figure 1
The Australian Twin Diabetes Mellitus Study. Of the 384 twin pairs approached for the Diabetes Study, type 1diabetes was found in 46 twin pairs,
type 2 diabetes was found in 113 pairs and gestational diabetes in 41 pairs (see text for details).
Table 2
Age and Body Mass Index (BMI) for Individuals with Diabetes Mellitus:
Type 1 Diabetes (T1D), Type 2 Diabetes (T2D) or Gestational Diabetes
(GD), at Onset of Disease and at Time of Interview
T1D T2D GD
Total 56 152 45
Sex
Male 20 61 —
Female 36 91 45
Age at onset
Mean (SD) 18.4 (11.5) 54.4 (13.9) 27.0 (5.0)
Median 15.0 55.0 27.0
Age at interview
Mean (SD) 35.3 (17.0) 63.7 (12.5) 39.4 (9.5)
Median 30.5 65.0 37.0
BMI at onset
Mean (SD) 19.2 (4.1) 29.5 (7.0) 25.9 (5.1)
BMI at interview
Mean (SD) 24.4 (4.2) 28.1 (5.2) 26.3 (4.7)
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of disease for T1D, T2D and GD was 19, 29 and 26
respectively and the mean ages at onset were 18.4,
54.4 and 27.0 years. There was a large, but nonsignifi-
cant, sex difference in age of onset for T1D (median
age 13.0 years for females and 20.5 years for males).
The effect was further increased by removing one
female reporting onset at age 54 from the sample (p =
.06). However, on further removing two males who
reported onset above age 40, resulting in a median age
of 17.5 years for men, the sex difference disappeared
(p = .45). There was no difference in age of onset in
T2D between men (54.0) and women (55.0; p = .21).
The numbers of twin pairs concordant and discor-
dant for T1D, T2D and GD are shown in Table 3.
There were four twin pairs who were discordant for
T2D where the co-twin had another type of diabetes
(for two pairs the co-twin had T1D, for one pair the
co-twin had GD and for another the co-twin had
IGT). Therefore, in preparing the datasets for the
analysis of the three main types of diabetes (T1D,
T2D and GD) included in this study, these twin pairs
were included in both datasets. That is, for a twin pair
where one individual has T2D and one has T1D, the
twin pair was included in both datasets; in the T1D
data the T2D co-twin, and in the T2D data the T1D
co-twin, were classified as unaffected for disease. As
such, the total number of twin pairs, as shown in
Figure 1, is 236.
Diabetes Concordance
Probandwise concordances (CpMZ, CpDZ), with 95%
CI, for the various types of diabetes are shown in
Table 4. The MZ and DZ concordances are signifi-
cantly different in both T1D (χ21 = 6.7, p < .01) and
T2D (χ 21 = 18.9, p < .001). Genetic risk can be
inferred from the concordance ratio (CpMZ/CpDZ),
which was 5.1, 5.3 and 2.5 for T1D, T2D and GD
respectively. For T1D, the MZ and DZ recurrence
risks (or population risk ratio, PPR = Cp/P, where P is
the population prevalence) were 203 and 40 respec-
tively. Similarly, for T2D the PPRMZ and PPRDZ were
8.3 and 0.64 respectively. For GD, the PPRMZ was 5.6
and the PPRDZ was 0.45. All three diseases have PPRMZ
greater than 4 PPRDZ, indicating epistasis, thus suggest-
ing these diseases are polygenic in nature.
There were no significant differences between con-
cordances of male and female MZ pairs for either
T1D (MZF: 0.52 [0.14–0.82]; MZM: 0.78
[0.26–0.97]), or T2D (MZF: 0.76 [0.53–0.91]; MZM:
0.62 [0.33–0.82]). Similarly, there was no significant
difference in MZ concordance if we stratified for age
of onset for either T1D (age of onset ≤ 11: 0.89
[0.44–0.99]; age of onset > 11: 0.71 [0.13–0.97]) or
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Figure 2
Distribution of age at onset for males (   ) and females (   ) diagnosed with Type 1 diabetes.
Table 3
Monozygotic and Dizygotic Twin pairs Concordant and Discordant for
Type 1, Type 2 and Gestational Diabetes Mellitus
Diabetes Type Concordant Discordant
MZ DZ MZ DZ
T1D 6 2 8 30
T2D 18 4 26 65
GD* 3 0 18 9
Table 4
Concordance Rates for Monozygotic and Dizygotic Twins with Type 1, Type 2 or Gestational Diabetes Mellitus 
Diabetes Type Probandwise Concordance
MZ DZ χ2 1 P value MZ/DZ Ratio
T1D .61 (.30–.83) .12 (.02–.34) 6.7 < .01 5.1
T2D .58 (.42–.72) .11 (.03–.24) 18.9 < .001 5.3
GD* .28 (.08–.55) .11 (.00–.55) 0.3 .60 2.5
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T2D (age of onset ≤ 54: 0.75 [0.50–0.90]; age of onset
> 54: 0.46 [0.24–0.67]).
Heritability
Variance component threshold models were fitted to
contingency tables for MZ and DZ twins constructed
from the combined QIMR-ATR Contingency Data
(Table 3). Prior to this, assumptions regarding the
homogeneity of thresholds across birth order and
zygosity were tested within a maximum likelihood
framework using the chi-square likelihood ratio test as
the statistical fit index. No effect of birth order or
zygosity (MZ vs. DZ) on thresholds (p > .05) was
found for any type of diabetes, resulting in the esti-
mate of a single threshold for each classification.
MZ and DZ co-twin correlations in liability to
disease were significantly different for T1D and
T2D (both p < .001) and for GD (p < .05,) and are
shown in Table 5.
A saturated model including ACE components of
variance was initially fitted to the data, with subse-
quent models testing the significance of A and C
parameters in explaining the trait variance. These
nested models were compared using the likelihood
ratio test, with fit indices given in Table 6.
Although the AE model is the more parsimonious
for T1D (AIC = –6.53) and T2D (AIC = –5.67), this
is considered to result from the small sample size as
illustrated by the broad and overlapping confidence
intervals of the MZ and DZ twin correlations (Table 5).
The crude genetic variance for the AE model accounts
for 96% and 93% of the total variance in T1D and
T2D respectively. However, it is well recognized that a
significant portion of the variance of these diseases is
due to environmental factors. The heritabilities from
the ACE models for T1D and T2D are 0.69
(0.26–0.99) and 0.73 (0.38–0.96) respectively, while
the estimates of shared environmental variance are 0.27
(0.00–0.67) and 0.20 (0.00–0.53). Thus, while our
sample size is too small to detect significant estimates of
genetic and shared environmental variance simultane-
ously (Martin et al., 1978), shared environmental
factors could be making a substantial contribution to
variance in liability to both diseases, which we do not
have to power to detect. For GD, our sample size is
even smaller and the absence of any concordant DZ
pairs ensures that the DZ correlation is negative. While
liability to GD is best explained by an AE model with a
heritability of 0.75 (0.00–0.90), our data are not
incompatible with a shared environmental component
as large as 76% of variance (Table 7).
Because age and BMI are potentially important
covariates, we repeated the variance components
analysis using raw data observations rather than
summed contingency tables, reading in individual
values of these variables as modifiers of the disease
threshold for each type of diabetes. However, since
these variables were not available for the ATR data,
this analysis was carried out on the QIMR data alone.
Therefore, the contingency table analysis described
above was repeated using the QIMR dataset alone to
allow a direct comparison of the effects of the covari-
ates on variance component estimates. For T1D there
was no effect of age or BMI on thresholds. However,
for T2D there were large effects of age (χ21 = 86.4,
p = .00) and BMI (χ21 = 77.3, p = .00) and therefore
these were included in the model. Similarly for GD,
for which the raw data analysis was carried out on
female twins only (n = 9741 individuals), age (χ21 =
Table 5
Co-Twin Correlations for Liability to T1D, T2D and GD: Chi-Square Tests
for Differences Between MZ and DZ Correlations Estimated by
Maximum Likelihood
Diabetes type Co-twin correlations (95%CI)
MZ DZ ( χ21)
T1D .96 (.86–.99) .61 (.32–.81) 11.21, p < .001
T2D .93 (.86–.97) .56 (.34–.72) 22.70, p < .001
GD .75 (.52–.90) –.26 (–1.0–.74) 6.65, p < .05
Table 6
Threshold Model Fit Indices for QIMR–ATR Contingency Data for T1D, T2D and GD
Diabetes Type Model χ2 df P AIC χ2 df p
T1D ACE 0.54 3 .91 –5.46
AE 1.47 4 .83 –6.53 0.94 1 .33
CE 11.21 4 .02 3.21 10.68 1 .00
E 86.34 5 .00 76.34 85.80 2 .00
T2D ACE 1.51 3 .68 –4.50
AE 2.37 4 .67 –5.67 0.86 1 .35
CE 22.70 4 .00 14.7 21.20 1 .00
E 195.18 5 .00 185.09 193.58 2 .00
GD ACE 3.89 3 .27 –2.11
AE 3.89 4 .42 –4.11 0.00 1 1
CE 6.65 4 .16 –1.36 2.76 1 —
E 30.29 5 .00 20.29 26.39 2 .00
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7.11, p = .03) and BMI (χ21 = 15.41, p = .00) were
included in the model.
The proportions of additive genetic, common and
unique environmental variance for T1D, T2D and
GD, with 95% confidence intervals, are given in
Table 7 for the combined contingency data, the
QIMR-only contingency data, and the QIMR raw
data to which age, sex and BMI covariates were fitted.
The QIMR-only data showed a smaller heritability
than the combined QIMR–ATR for T1D, but given
the small sample sizes (there were only 31 individuals
with T1D in the QIMR data), this is considered to be
an issue of power rather than a real effect, as illus-
trated by the very wide 95% confidence intervals.
However, for T2D liability the variance components
are very similar for the combined (A = 0.73, C = 0.20,
E = 0.07) and QIMR-only (0.70, 0.18, 0.11) contin-
gency data, and the same is true for GD.
The effects of including BMI and age as covariates
in the model for the T2D disease threshold can be seen
by comparing the variance components for the ACE
model in the QIMR contingency data (0.70, 0.18,
0.11) versus those for the raw data analysis (0.72,
0.07, 0.21). Since co-twins are the same age, removing
its effects reduces the shared environmental variance
from 18% to 7% of the total. Since BMI is influenced
by both genetic and environmental factors, removing
its effects will have unpredictable consequences for the
variance components of liability to T2D, in this case
increasing E from 11 to 21% and leaving the genetic
influence almost unchanged (70% versus 72%).
Similarly, by correcting GD thresholds for age and
BMI, the genetic variance estimate decreases from
76% to 71%.
Diabetes and Body Mass Index
The association between diabetes and BMI is
further explored in Table 8, which shows that the
affected twin–unaffected twin difference in weight
of DZ twin pairs who are discordant for either T2D
or GD is significantly larger than the corresponding
difference for discordant MZ twin pairs. For T1D this
contrast was not significant (t = 1.16, p = .25). Table 8
confirms the importance of weight as a risk factor for
T2D and GD, but goes further in showing that both
genetic and unique environmental influences mediate
this risk. In all twins, the heavier twin is at elevated
risk. If this were mediated only by environmental
factors unique to the individual, we would see the
same difference within MZ and DZ discordant pairs.
That the DZ difference is so much larger than for MZ
discordant pairs confirms that genetic factors influenc-
ing weight also influence T2D and GD risk.
Table 7
Proportions of Additive Genetic, Common and Unique Environmental Variance for T1D, T2D and GD, Including 95% Confidence Intervals
Dataset Model Diabetes Type Point Estimates (95% CI)
A C E
(Additive Genes) (Shared Environment) (Unique Environment)
QIMR + ATR (Contingency table data) ACE T1D .69 (.26-.99) .27 (.00-.67) .04 (.01-.14)
T2D .73 (.38–.96) .20 (.00–.53) .07 (.03–.14)
GD .75 (.00–.90) .00 (.00–.76) .25 (.10–.49)
AE T1D .96 (.87–.99) — .04 (.01–.13)
T2D .93 (.87–.97) — .07 (.03–.13)
GD .75 (.51–.90) — .25 (.10–.49)
QIMR (Contingency table data) ACE T1D .56 (.05–.99) .39 (.00–.80) .05 (.01–.23)
T2D .70 (.30–.94) .18 (.00–.56) .11 (.05–.20)
GD .76 (.00–.91) .00 (.00–.81) .24 (.09–.50)
QIMR (Raw data) ACE T1D .56 (.05–.99) .39 (.00–.80) .05 (.01–.23)
T2D .72 (.20–.88) .07 (.00–.53) .21 (.12–.34)
GD .71 (.00–.88) .00 (.00–.84) .30 (.12–.58)
Note: The estimates for the QIMR raw data are derived from a model which includes the effects of age and BMI on thresholds for T2D and GD.
Table 8
Weight Differences Between Twin1 and Twin 2 (Affected Twin–Unaffected Twin) for Twin Pairs Discordant for Either T2D or GD and Test 
of Significance of This Difference Between MZ and DZ Pairs
Diabetes Type Zygosity Discordant Pairs (n) Mean Weight Differences t p value
(Aff-Unaff; Kg)
T2D MZ 25 5.3
6.30 .000DZ 64 18.2
GD MZ 17 8.1
2.56 .017
DZ 11 16.2
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Bivariate Cholesky decomposition analyses were
carried out to quantify the proportion of genetic vari-
ance contributing to the shared variance between BMI
and disease status for T2D and GD. The results of
each analysis showed strong genetic mediation of the
relationship between T2D and both GD and BMI,
with no significant influence of the common environ-
ment supported in either analysis. In the saturated
model (i.e., ACE), for T2D the relationship with BMI
could be entirely explained by additive genes, and for
GD, 77% of the covariance with BMI was explained
by additive genes. To simplify the model, all sources of
common environmental variance were removed (in
both analyses p = 1); additive genetic variance was sig-
nificant (p < .01) and retained in both models.
Figure 3 depicts the standardized path coefficients
influencing the traits in the AE model; 95% confi-
dence intervals that include zero indicate that the path
coefficient is not significant. In both analyses, the
unique environmental pathway between BMI and dia-
betes was not significant. Genes influencing BMI
explained 18% of variance in T2D and 7% of vari-
ance in GD.
Diabetes Prevalence
T2D and GD prevalences, which were taken from
thresholds generated from the ACE models for the
diabetes sample, are very low compared with disease
prevalences from the Australian population (Dunstan
et al., 2002); these comparisons are shown in Table 9.
T1D, however, is comparable with the estimated pop-
ulation prevalence. The prevalences of the three
diseases taken from the QIMR data are approximately
double that of the total data (QIMR+ATR) suggesting
that the screening for diabetes was more effective
using just the QIMR population. This is demonstrated
by examining the double sampled twins (Table 10);
Table 9
Estimates of Disease Prevalence From Our Sample Compared With the Australian Population
Dataset Diabetes Type Threshold Prevalence Population Prevalence 
(Per 10,000) (Per 10,000)
QIMR+ATR (contingency tables) T1D –2.9857 14 30
T2D –2.7048 34 700
GD –3.0590 11 500
QIMR (contingency tables) T1D –2.8411 22
T2D –2.4098 80
GD –2.8615 21
QIMR (raw data) T1D –2.8518 22
T2D –2.9703 23
GD –2.8299 23
A A
E E
Type 2
Diabetes
.80
(.77, .82)
.43
(.37, .55)
.83
(.73, .89)
.60
(.57, .63)
.02
(0, .12)
.36
(.25, .36)
A A
Gestational
Diabetes
.80
(.77, .83)
.27
(.08, .45)
.83
(.64, .94)
.59
(.55, .64) .01
(0, .23)
.48
(.47, .71)
E E
b)
BMI BMI
Figure 3
Bivariate Cholesky models depicting the standardized path coefficients for additive genetic and unique environmental influences on (a) BMI and
Type 2 Diabetes, and (b) BMI and Gestational Diabetes.
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that is twin pairs who were screened for diabetes in
both the QIMR data and the ATR data.
The specificity, that is, the proportion of truly
nondiabetics identified by the sampling frame, was
~99% for both QIMR and ATR datasets. The sensi-
tivity of ATR and QIMR datasets to identify twin
pairs where one or both has diabetes was 0.58 and
0.74 respectively. Thus, based on the double sampled
twins, it is estimated that 181 twin pairs with dia-
betes were missed from the ATR sampling frame and
25 from QIMR.
Comorbidity with Asthma
All the surveys that probed diabetes also asked about
asthma, so we were able to see whether there was any
comorbidity. Contrary to some data suggesting an
inverse relationship between type 1 diabetes and
asthma, we found no support for such a relationship
in our data (p = .39).
Discussion
The nosology and etiology of diabetes remain obscure
and there are intensive international efforts underway
to dissect the genetic and environmental risk factors
influencing the different subtypes (Salonen et al.,
2007; Sandhu et al., 2007; Todd et al., 2007; Sladek et
al., 2007; Zeggini et al., 2007; Pascoe et al., 2007),
and the extent to which these overlap between sub-
types. Just as twins have been important in the past in
demonstrating the major role of genetic factors in dia-
betes (Kyvik et al., 1995; Hyttinen et al., 2003;
Benyamin et al., 2007), once the principal genetic vari-
ants have been identified they will be even more useful
in helping to dissect the interactions of genetic and
environmental risk factors in disease causation and the
role of epigenetic factors. Discordant MZ pairs will be
particularly useful in examining G x E interaction.
Our primary goal, therefore, was to use the large
Australian Twin Registry to identify a sample of well-
characterised diabetic twin pairs who might be a
useful resource for more detailed molecular and G x E
investigations. In the course of doing so, we have been
able to confirm and extend a number of key findings
about the genetic epidemiology of diabetes.
The Australian Twin Registry was founded almost
thirty years ago and has been funded continuously
since 1980 by the National Health and Medical
Research Council as a resource for biomedical
research. About 30,000 pairs, of both sexes and
zygosity groups, and all ages, have enrolled voluntar-
ily, or been enrolled by their parents. At frequent
intervals, subsets of these twins have been surveyed by
various researchers, or by the ATR itself. We have
taken advantage of disease checklists included in
surveys on nine different occasions during the life of
the ATR, to identify twins with diabetes. Follow-up
questionnaires to the twins and their doctors have
confirmed diagnoses and allowed us to classify the
twins into disease subtypes.
Our analyses found prevalences well below those
reported for the population for T2D and GD
(although comparable for T1D) and suggest that the
surveys conducted by QIMR have been reasonably
efficient (74%) in identifying diabetic twin pairs,
while those conducted by the ATR, mainly in the
course of recruiting the twins, have been less effi-
cient (58%). Based on the Australian MZ twinning
rate, and the incidence of T1D at the time of the
study, we would expect a total of ~400 MZ twin
pairs containing one or two cases of T1D in the
Australian population. The deficiency of T2D cases
will reflect the more cryptic nature of this disease
and the relatively young age of the ATR catchment,
while the lower than population prevalence of GD
may reflect women’s poor recall, or confusion about
complications of their pregnancies. It is known that
T2D is underdiagnosed in Australia, as in other
Western countries.
As a result, although we were recruiting from a
pool of almost 20,000 pairs, the number of twins
identified with any subtype was not large, and conse-
quently the power to discriminate between models of
causation was not high. Although we could reject
purely environmental models of causation and esti-
mated very high heritabilities for all three major
subtypes, we had little power to simultaneously detect
shared environmental influences, even if these had
been large. For T2D, correction for increasing inci-
dence with advancing age reduced the estimate of
shared environmental variance, but did not increase
the heritability, rather increasing the variance due to
unique environmental factors.
The involvement of excess body weight in T2D
risk was seen quite dramatically in twin pairs discor-
dant for the disease. In discordant MZ pairs, the twin
affected with T2D was some 5kg heavier than the
unaffected twin, and in discordant DZ pairs this dif-
ference rose to 18kg, confirming that both genetic and
environmental factors are involved in the comorbidity
of high BMI and T2D. The full bivariate genetic
analysis of BMI and T2D found that while the genetic
correlation was .46, the environmental correlation
was only .06. That is, 20% of the genetic influence on
T2D was contributed by genes with a joint influence
on BMI. The corresponding figure for unique environ-
mental factors was only 0.3%. The size of the genetic
correlation is in keeping with the roles of the newly
Table 10
Capture-Recapture: Twin Pairs Present in Both the QIMR and the ATR
Datasets
ATR Total
+ –
QIMR + 98 72 170
– 34 4219 4253
Total 132 4291 4423
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discovered genes controlling susceptibility to T2D
such as FTO (see the review of Frayling, 2007).
In contrast to some other epidemiological studies
(Tirosh et al., 2006), we did not demonstrate a nega-
tive correlation between asthma and T1D. This may
reflect the sample size recruited, as the reported rela-
tive risks are not large.
In conclusion, genetic analysis of this large
sample of twins confirms the current broad model
of diabetes, especially with respect to pleiotropic
genes influencing T2D. Twins ascertained through
this work are undergoing more detailed follow-up,
which will include molecular genetic studies, allow-
ing assessment of specific genetic contributions to
overall familial resemblance
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